Luminyst
Product Lifecycle Management
Structured Product Development Management for Biotech
Product Development:
The process of transforming customer requirements and product concepts into a functional, market ready, product
Product Lifecycle Management (PLM) Framework
​
Provides a playbook of Product Development for each technical function, divided into chapters, for easy, organized, and predictable execution from Discovery to Launch​
Luminyst Software Solution
​​​
Leverages the PLM framework- but doesn’t over burden the users with the details. Everything is front and center through a software landing page, propelling the program forward in a transparent manner, and you don’t need to be a business process expert to do so.
Landing page concept
​IF you are a Head of​​​​
-
Operations
-
Program Management
-
Product Development
In A Small Pharma and Science CompanY
YOU NeeD...
-
Easy structure and organization for product development
-
To focus product development on meeting customer needs
-
To do more PMing with fewer resources
-
More transparency, discipline or predictability within their organization
You Can Have...
-
​Structured and organized product development
-
Focused on customer needs
-
Transparent program status
-
Easy access to relevant program deliverables.
You Experience...
-
Intentional development
-
Customer focused, market ready product
-
Market entry / IPO / Investment Round ready -always
-
Real time program and risk status awareness
-
High level productivity with lean staffing
Your Product Profile and Progress Dashboard
Phase 1
40%
Progress to phase gate
Upcoming phase gate
10
Dec
2024
Jun 2026
Launch Date
Progress to Launch
You Are Here
CUSTOMER PROBLEM STATEMENT
There is a public need for pathogen profiling in the context of blood diagnostic testing for NICU infants that is accurate and rapid.
Market Differentiation
Our microfluidic device and machine learning technologies operate at lower cost and higher accuracy for blood pathogen ID with rapid readout of potentially deadly pathogenic infections .
Target Market
Minimal
Hospital screening test for adolescents, men and women in high-prevalence settings
Target
Expand to pregnant and breastfeeding women in hospital settings with high pathogen prevalence, neonates and infants with pathogen exposure.
Value Claims
Instrument
Evidence of broad coverage, high sensitivity and accurate pathogenic identification. Ease of use, small footprint.
Consumable
Reduced reagent use, no mixing, cartridge based systems with minimal waste and excess packaging.
Status to Plan
At RIsk
Requires Attention
On Track
Status to Plan
At RIsk
Requires Attention
On Track
Status to Plan
At RIsk
Requires Attention
On Track
CMC
MFG Assessment Rating:
Instrument ___
Flowcell ____
Consumables ____
Enter rating fro Manufacturability Assessment worksheet
(1-2 = Unfavorable, 2-2.5 = Med, 2.5-3= Favorable)
Status to Plan
At RIsk
Requires Attention
On Track
Program Plan
Status to Plan
At RIsk
Requires Attention
On Track
2026
Status to Plan
At RIsk
Requires Attention
On Track
Status to Plan
At RIsk
Requires Attention
On Track